Why Cell-Free DNA Can Be a “Game Changer” for Lung Allograft Monitoring for Rejection and Infection

Abstract excerpt

Purpose of Review: Although there has been improvement in short-term clinical outcomes for patients following lung transplant (LT), advances have not translated into longer-term allograft survival. Furthermore, invasive biopsies are still standard of practice for monitoring LT recipients for allograft injury. We review the relevant literature supporting the role of using plasma donor-derived cell-free DNA...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Renal Transplantation Outcomes and Treatments
• Share to Transplantation: Methods and Outcomes
• Share to Viral-associated cancers and disorders